Proactive Investors - Run By Investors For Investors

Genus raises £68mln through share placing

The placing price represents a 7.8% discount to the closing price of 2,386p on 6 December 2018
Genus raises £68mln through share placing
Genus was earlier this week upgraded to a ‘buy’ from a ‘hold’ rating by broker Kepler Chevreux

Genus PLC (LON:GNS) said on Friday it had raised £68mln through a share placing.

The animal genetics company said 3.1mln new shares were issued to new and existing investors at a price of 2,200p per placing share.

READ: Genus upgraded by Kepler as African swine fever concerns abate

The placing price represents a 7.8% discount to the closing price of 2,386p on 6 December 2018.

Genus was earlier this week upgraded to a ‘buy’ from a ‘hold’ rating by broker Kepler Chevreux who believes the fall in the animal genetics company’s share price on the back of fears over the outbreak of African swine fever has been overdone.

Genus’s share price is 25% off the peak it reached last July, triggered by the outbreak of African swine fever (ASF) in China.

Peel Hunt and Liberum acted as joint book runners on the placing.

View full GNS profile View Profile

Genus Timeline

Newswire
February 16 2015

Related Articles

Artificial intelligence
October 29 2018
E-therapeutics believes it is now focused on the right activities
blood
December 03 2018
Feraccru already has EU approval while in Switzerland the drug can be used for iron deficiency anaemia in adults with inflammatory bowel disease
surgeons working
September 03 2018
Chief executive Steve Couldwell also told investors the regenerative medicines specialist had identified a number of potential new commercial opportunities it was “actively pursuing”

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use